ACE2 and COVID-19: It has been previously suggested that ACE-2 deficiency in COVID-19 contributes to increased inflammation and cytokine storms through increased Ang II levels, decreased ACE-2/MasR axis activity, and activation of the BKB1R axis and the complement system (Kim et al., 2020).